PAM
SLDB icon

Panagora Asset Management’s Solid Biosciences SLDB Stock Holding History

Panagora Asset Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-91,095
Closed -$656K – 1287
2026
Q1 		$656K Sell
91,095
-135,660
-60% -$872K ﹤0.01% 798
2025
Q4 		$1.28M Sell
226,755
-170,433
-43% -$924K ﹤0.01% 651
2025
Q3 		$2.45M Buy
+397,188
New +$2.32M 0.01% 479
2022
Q1 		– Sell
-8,120
Closed -$213K – 1590
2021
Q4 		$213K Buy
8,120
+138
+2% +$4.22K ﹤0.01% 1474
2021
Q3 		$286K Buy
7,982
+7,934
+16,529% +$337K ﹤0.01% 1533
2021
Q2 		$3K Sell
48
-49
-51% -$3.24K ﹤0.01% 2588
2021
Q1 		$8K Hold
97
– – ﹤0.01% 2468
2020
Q4 		$11K Buy
97
+49
+102% +$3.1K ﹤0.01% 2282
2020
Q3 		$1K Buy
+48
New +$1.84K ﹤0.01% 2659
2020
Q2 		– Sell
-992
Closed -$36K – 2646
2020
Q1 		$36K Buy
+992
New +$49.1K ﹤0.01% 1962

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Panagora Asset Management's SLDB Position: Q2 2026 in Review

Panagora Asset Management sold out of Solid Biosciences (SLDB) in Q2 2026, closing a stake of 91,095 shares — an estimated $656K sold.

Panagora Asset Management first reported a position in SLDB in Q1 2020 and held it in 10 quarters. The position peaked at $2.45M in Q3 2025. 156 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Panagora Asset Management reported no remaining Solid Biosciences position as of Q2 2026 after selling out during the quarter.
  • Panagora Asset Management sold 91,095 Solid Biosciences shares in Q2 2026, an estimated $656K.
  • Panagora Asset Management first reported a position in Solid Biosciences in Q1 2020 and held it in 10 quarters.
  • Panagora Asset Management's Solid Biosciences position peaked at $2.45M in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.